Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Researcher

Jennyfer Bultinck

11 Results

2020

Safe eradication of large established tumors using neovasculature-targeted tumor necrosis factor-based therapies

Leander HuygheAlexander Van ParysAnje CauwelsSandra Van LintStijn De MunterJennyfer BultinckLennart ZabeauJeroen HostensAn GoethalsNele VanderroostAnnick VerheeGilles UzeNiko KleyFrank PeelmanBart VandekerckhovePeter BrouckaertJan Tavernier

A1 Journal Article in EMBO MOLECULAR MEDICINE

2017

A safe and highly efficient tumor-targeted type I interferon immunotherapy depends on the tumor microenvironment

Anje CauwelsSandra Van LintGeneviève GarcinJennyfer BultinckFranciane PaulSarah GerloJosé Van Der HeydenYann BordatDominiek CatteeuwLode De CauwerElke RoggeAnnick VerheeGilles UzéJan Tavernier

A1 Journal Article in ONCOIMMUNOLOGY

2014

Nitric oxide production by endotoxin preparations in TLR4-deficient mice

Anje CauwelsJennyfer BultinckRenske De ZwaefBenjamin VandendriesscheStefan MagezPeter Brouckaert

A1 Journal Article in NITRIC OXIDE-BIOLOGY AND CHEMISTRY

2013

TLR2 activation causes no morbidity or cardiovascular failure, despite excessive systemic nitric oxide production

Anje CauwelsBenjamin VandendriesscheJennyfer BultinckBenedicte DescampsElke RoggeTom Van NieuwenhuysenMagdalena SipsChristian VanhovePeter Brouckaert

A1 Journal Article in CARDIOVASCULAR RESEARCH

2012

Protein-protein interactions: network analysis and applications in drug discovery

Jennyfer BultinckSam LievensJan Tavernier

A1 Journal Article in CURRENT PHARMACEUTICAL DESIGN

2011

STAT3 transcriptional activity is controlled by regulated acetylation

Jan TavernierLaura IcardiViola GesellchenRaffaele MoriSam LievensSven EyckermanJennyfer BultinckM BoutrosKarolien De Bosscher

2007

Excessive endogenous systemic no production is not sufficient to cause shock, morbidity or mortality

Anje CauwelsJennyfer BultinckRenske De ZwaefPeter Brouckaert

2006

Systemic NO production during (septic) shock depends on parenchymal and not on hematopoietic cells: in vivo iNOS expression pattern in (septic) shock

Jennyfer BultinckPatrick SipsLuc VakaetPeter BrouckaertAnje Cauwels

A1 Journal Article in FASEB JOURNAL

The in vivo contribution of hematopoietic cells to systemic TNF and IL-6 production during endotoxemia

Jennyfer BultinckPeter BrouckaertAnje Cauwels

A1 Journal Article in CYTOKINE

2005

Dual role of endogenous nitric oxide in tumor necrosis factor shock: induced NO tempers oxidative stress

Anje CauwelsJennyfer BultinckPeter Brouckaert

A1 Journal Article in CMLS-CELLULAR AND MOLECULAR LIFE SCIENCES

1994

FOAM CELL REPLICATION AND SMOOTH-MUSCLE CELL APOPTOSIS IN HUMAN SAPHENOUS-VEIN GRAFTS.

MM KOCKXBA CAMBIERHilde BortierGR DEMEYERSC DECLERCQPA VANCAUWELAERTJennyfer Bultinck

A1 Journal Article in HISTOPATHOLOGY